Stock Market

Home > Markets-Economic Times > Glenmark Pharma launches anti-diabetes drug Remogliflozin in India

Glenmark Pharma launches anti-diabetes drug Remogliflozin in India

April 30, 2019
Glenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.

from Markets-Economic Times http://bit.ly/2Lc0JyS

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )
Powered by Blogger.